Literature DB >> 17589261

Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction.

Brian Olack1, Raavi Gupta, Glen S Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17589261     DOI： 10.1097/SAP.0b013e31804d442e

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN： 0148-7043            Impact factor:   1.539


× No keyword cloud information.
  16 in total

Review 1.  Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.

Authors:  Tessa L St Cyr; Barbara A Pockaj; Donald W Northfelt; Fiona E Craig; Mark W Clemens; Raman C Mahabir
Journal:  Plast Surg (Oakv)       Date:  2020-05-21       Impact factor: 0.947

Review 2.  Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis.

Authors:  Philip A Thompson; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

Review 3.  Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules.

Authors:  Mark W Clemens; Maurizio Bruno Nava; Nicola Rocco; Roberto N Miranda
Journal:  Gland Surg       Date:  2017-04

4.  Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Authors:  Mark W Clemens; L Jeffrey Medeiros; Charles E Butler; Kelly K Hunt; Michelle A Fanale; Steven Horwitz; Dennis D Weisenburger; Jun Liu; Elizabeth A Morgan; Rashmi Kanagal-Shamanna; Vinita Parkash; Jing Ning; Aliyah R Sohani; Judith A Ferry; Neha Mehta-Shah; Ahmed Dogan; Hui Liu; Nora Thormann; Arianna Di Napoli; Arianna DiNapoli; Stephen Lade; Jorge Piccolini; Ruben Reyes; Travis Williams; Colleen M McCarthy; Summer E Hanson; Loretta J Nastoupil; Rakesh Gaur; Yasuhiro Oki; Ken H Young; Roberto N Miranda
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

5.  Anaplastic large cell lymphoma associated with breast implants.

Authors:  Shalini Ravi-Kumar; Omid Sanaei; Mohammad Vasef; Ian Rabinowitz; Mohammad Houman Fekrazad
Journal:  World J Plast Surg       Date:  2012-01

6.  Primary anaplastic large-cell lymphoma associated with breast implants.

Authors:  Leslie Popplewell; Sandra H Thomas; Qin Huang; Karen L Chang; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

7.  Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.

Authors:  Roberto N Miranda; Tariq N Aladily; H Miles Prince; Rashmi Kanagal-Shamanna; Daphne de Jong; Luis E Fayad; Mitual B Amin; Nisreen Haideri; Govind Bhagat; Glen S Brooks; David A Shifrin; Dennis P O'Malley; Chan Y Cheah; Carlos E Bacchi; Gabriela Gualco; Shiyong Li; John A Keech; Ephram P Hochberg; Matthew J Carty; Summer E Hanson; Eid Mustafa; Steven Sanchez; John T Manning; Zijun Y Xu-Monette; Alonso R Miranda; Patricia Fox; Roland L Bassett; Jorge J Castillo; Brady E Beltran; Jan Paul de Boer; Zaher Chakhachiro; Dongjiu Ye; Douglas Clark; Ken H Young; L Jeffrey Medeiros
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

Review 8.  Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.

Authors:  Sara K Story; Michael K Schowalter; Larisa J Geskin
Journal:  Oncologist       Date:  2013-02-21

9.  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.

Authors:  Evan A Farkash; Judith A Ferry; Nancy Lee Harris; Ephraim P Hochberg; Ronald W Takvorian; Dan S Zuckerman; Aliyah R Sohani
Journal:  J Hematop       Date:  2009-08-20       Impact factor: 0.196

10.  Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.

Authors:  Eva V George; John Pharm; Courtney Houston; Semar Al-Quran; Grey Brian; Huijia Dong; Wang Hai; Westley Reeves; Li-Jun Yang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.